Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03833245 · ClinicalTrials.gov registry record · NA

Optimizing Pregnancy and Treatment Interventions for Moms 2.0

A NA study, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
102
Enrollment target

NCT03833245: Completed NA study, sponsored by University of Utah.

NCT03833245 is a NA study that has completed, run by University of Utah. The registered enrollment target is 102 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03833245, a NA study, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
102 participants
Enrollment target

Study Summary

The US opioid epidemic continues to result in serious health consequences for pregnant and postpartum women. In the US from 2007 to 2012, an average of 21,000 pregnant women each year reported past month opioid misuse. This study aims to provide rapid and targeted primary prevention activities aimed at assisting pregnant women with opioid use disorder (OUD) to become linked to and retained in treatment in order to reduce harms to them (including overdose) and their offspring.

Primary Outcome

Percentage of days of days of attending outpatient and inpatient Substance Use Disorder treatment.

Interventions

  • BEHAVIORAL Patient Navigation

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2019-03-11
Est. Completion 2022-10-01
Phase NA
University of Utah

818 total trials

What the finished NCT03833245 record still lists

NCT03833245 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Patient Navigation is the first listed.

NCT03833245 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03833245 about?

NCT03833245 is a clinical study titled "Optimizing Pregnancy and Treatment Interventions for Moms 2.0". The US opioid epidemic continues to result in serious health consequences for pregnant and postpartum women. In the US from 2007 to 2012, an average of 21,000 pregnant women each year reported past month opioid misuse. This study aims to provide rapid and targeted primary prevention activities aimed...

What is the current status of trial NCT03833245?

This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2019-03-11. Estimated completion is 2022-10-01.

What interventions are being tested in trial NCT03833245?

The interventions under investigation include: Patient Navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03833245?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03833245's enrollment target sits among peer trials

102 837th of 2000 higher than 1,161 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03704662 · 102 participants · NA

    Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

  • NCT04174742 · 102 participants

    Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

  • NCT04275362 · 102 participants

    Gait Analysis of a Lateral-Pivot Design Total Knee Replacement

  • NCT04541082 · 102 participants · Phase 1

    Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03833245, the US trial registry maintained by the National Library of Medicine. NCT03833245 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.